Quarterly report · Q2
7634.TEDINET S100S91Y
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥13.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥879m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥806m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥908m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥914m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥621m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥560m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥623m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥564m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥21.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥21.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥20.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥15.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥15.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥967m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥816m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥601m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥230m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥454m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥958m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥483m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥199.16 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.56 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥402.98 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥105.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥79m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥380m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥678m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥658m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥264m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥800m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥879m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥84m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥402m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥588m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥545m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥193m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥19m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥721m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥806m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 503
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 543000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.175 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 203000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.065 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 200000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.064 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 162000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.052 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 110000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.035 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 102000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.033 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 100000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.032 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 71000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.023 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 69000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.022 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 59000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.019 | |
| Number of shares held | CurrentQuarterInstant | 1624000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.521 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 304200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 31106 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 3110600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 3420000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 31106 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 304200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 304200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.089 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 304200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 304200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.089 | |
| Cash and deposits | Prior1YearInstant | 9031480000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 8919812000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 2732102000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 2511416000 | JPY |
| Inventories | Prior1YearInstant | 223185000 | JPY |
| Inventories | CurrentQuarterInstant | 247424000 | JPY |
| Other ca | Prior1YearInstant | 93905000 | JPY |
| Other ca | CurrentQuarterInstant | 129379000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -13781000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -6833000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |